Goldman Sachs Group Inc Eli Lilly & CO Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $161 Million - $200 Million	-208,500 Reduced 61.29%	131,700 $117 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $192 Million - $241 Million	265,300 Added 354.21%	340,200 $308 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $34.2 Million - $45.7 Million	-57,700 Reduced 43.51%	74,900 $58.3 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $7.77 Million - $9.16 Million	14,800 Added 12.56%	132,600 $77.3 Million
Q3 2023 May 14, 2024	SELL	$434.7 - $599.3 $6.43 Million - $8.87 Million	-14,800 Reduced 11.16%	117,800 $63.3 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $18.2 Million - $25.1 Million	-41,800 Reduced 26.19%	117,800 $63.3 Million
Q2 2023 May 14, 2024	BUY	$350.74 - $468.98 $27.2 Million - $36.3 Million	77,500 Added 94.4%	159,600 $74.8 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $27.2 Million - $36.3 Million	77,500 Added 94.4%	159,600 $74.8 Million
Q1 2023 May 14, 2024	SELL	$310.63 - $364.82 $45.8 Million - $53.8 Million	-147,400 Reduced 64.23%	82,100 $28.2 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $45.8 Million - $53.8 Million	-147,400 Reduced 64.23%	82,100 $28.2 Million
Q4 2022 May 14, 2024	BUY	$321.55 - $374.67 $44.7 Million - $52 Million	138,900 Added 153.31%	229,500 $84 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $44.7 Million - $52 Million	138,900 Added 153.31%	229,500 $84 Million
Q3 2022 May 14, 2024	SELL	$296.48 - $337.87 $7.71 Million - $8.78 Million	-26,000 Reduced 22.3%	90,600 $29.3 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $7.71 Million - $8.78 Million	-26,000 Reduced 22.3%	90,600 $29.3 Million
Q2 2022 May 14, 2024	SELL	$278.73 - $327.27 $4.46 Million - $5.24 Million	-16,000 Reduced 12.07%	116,600 $37.8 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $6.22 Million - $7.3 Million	-22,300 Reduced 16.05%	116,600 $37.8 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $9.27 Million - $11.5 Million	39,500 Added 39.74%	138,900 $39.8 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $11.2 Million - $13.9 Million	49,900 Added 100.81%	99,400 $27.5 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $11 Million - $13.5 Million	49,500 New	49,500 $11.4 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$73 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.7 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account